Plain-English translation of NCT06439173 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at a common side effect that happens after —a type of immunotherapy for lymphoma where doctors reprogram your own immune cells to fight cancer. Some patients develop low blood cell counts (called cytopenias) weeks or months after treatment, which can cause serious health problems. Researchers want to understand why this happens and test whether treatments made from healthy donor stem cells might help repair the bone marrow and restore normal blood cell production.
Low blood cell counts after CAR-T therapy are one of the most common long-term complications, but doctors don't have proven treatments to fix it. This study exists to understand what goes wrong in the bone marrow after this therapy and to test whether repairing the bone marrow environment with stem cell treatments could help patients recover.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will collect blood samples and bone marrow samples from you at different time points—before your CAR-T therapy and at follow-up visits afterward. They will analyze these samples in the laboratory and compare results between patients who develop low blood cell counts and those who don't. The study also involves laboratory testing of potential stem cell treatments to see whether they could help restore healthy blood cell production.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Spain